Cargando…

Optimization and Stability Testing of Four Commercially Available Dried Blood Spot Devices for Estimating Measles and Rubella IgG Antibodies

Blood collection using dried blood spots (DBS) provides an easier alternative to venipuncture for sample collection, transport, and storage but requires additional processing that can cause variability in results. Whole-blood samples spotted on four DBS devices and respective paired serum samples we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaduskar, Ojas, Bhatt, Vaishali, Prosperi, Christine, Hayford, Kyla, Hasan, Alvira Z., Deshpande, Gururaj Rao, Tilekar, Bipin, Vivian Thangaraj, Jeromie Wesley, Kumar, Muthusamy Santhosh, Gupta, Nivedita, Murhekar, Manoj V., Moss, William J., Mehendale, Sanjay M., Sangal, Lucky, Sapkal, Gajanan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386427/ https://www.ncbi.nlm.nih.gov/pubmed/34259563 http://dx.doi.org/10.1128/mSphere.00490-21

Ejemplares similares

Implementing Serosurveys in India: Experiences, Lessons Learned, and Recommendations
por: Hasan, Alvira Z., et al.
Publicado: (2021)

Diagnostic Accuracy of Dried Blood Spots Collected on HemaSpot HF Devices Compared to Venous Blood Specimens To Estimate Measles and Rubella Seroprevalence
por: Prosperi, Christine, et al.
Publicado: (2021)

Experiences of sharing results of community based serosurvey with participants in a district of Maharashtra, India
por: Salvi, Neha, et al.
Publicado: (2022)

Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: a before-and-after cross-sectional household serosurvey in four districts, 2018–2020
por: Murhekar, Manoj V, et al.
Publicado: (2022)

Understanding the dynamics of IgM & IgG antibodies in COVID-19-positive patients
por: Kaduskar, Ojas, et al.
Publicado: (2022)

Measles and rubella elimination: protecting children through immunization in South-East Asia Region (SEAR)
por: Bahl, Sunil, et al.
Publicado: (2023)

1171. Measles and Rubella Seroprevalence among HIV-infected and uninfected Children and Adults in Zambia
por: Yang, Yangyupei, et al.
Publicado: (2021)

Molecular characterization of chikungunya virus from urbanized villages of Pune, Maharashtra, India, 2016
por: Deshpande, Gururaj Rao, et al.
Publicado: (2018)

Expansion of the measles and rubella laboratory network, India
por: Sharma, Deepa, et al.
Publicado: (2022)

Longitudinal clinico-serological analysis of anti-nucleocapsid and anti-receptor binding domain of spike protein antibodies against SARS-CoV-2
por: Deshpande, Gururaj Rao, et al.
Publicado: (2021)

Progress Toward Measles and Rubella Elimination — India, 2005–2021
por: Murugan, Ratnesh, et al.
Publicado: (2022)

Impact of a Measles and Rubella Vaccination Campaign on Seroprevalence in Southern Province, Zambia
por: Carcelen, Andrea C., et al.
Publicado: (2021)

Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients
por: Deshpande, Gururaj Rao, et al.
Publicado: (2020)

Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018–20
por: Prosperi, C., et al.
Publicado: (2023)

Molecular aspects of the teratogenesis of rubella virus
por: George, Suji, et al.
Publicado: (2019)

Benefits and Challenges in Using Seroprevalence Data to Inform Models for Measles and Rubella Elimination
por: Winter, Amy K, et al.
Publicado: (2018)

Two-dose measles–rubella vaccine schedule for measles–rubella elimination
por: John, T. Jacob
Publicado: (2023)

How much does it cost to measure immunity? A costing analysis of a measles and rubella serosurvey in southern Zambia
por: Carcelen, Andrea C., et al.
Publicado: (2020)

External quality assurance of serological diagnosis of dengue, chikungunya and Japanese encephalitis virus infection
por: Deshpande, Gururaj Rao, et al.
Publicado: (2022)

Previous SARS-CoV-2 Infection Status Among the Current RT-PCR-Positive Individuals Affected During the Second Wave of COVID-19 Infections in Chennai, India
por: Thangaraj, Jeromie Wesley Vivian, et al.
Publicado: (2022)

Comparison of measles IgG enzyme immunoassays (EIA) versus plaque reduction neutralization test (PRNT) for measuring measles serostatus: a systematic review of head-to-head analyses of measles IgG EIA and PRNT
por: Lutz, Chelsea S., et al.
Publicado: (2023)

Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG
por: Sapkal, Gajanan, et al.
Publicado: (2020)

Leveraging a national biorepository in Zambia to assess measles and rubella immunity gaps across age and space
por: Carcelen, Andrea C., et al.
Publicado: (2022)

Burden of congenital rubella syndrome (CRS) in India based on data from cross-sectional serosurveys, 2017 and 2019–20
por: Shanmugasundaram, Devika, et al.
Publicado: (2021)

Difficulties in Eliminating Measles and Controlling Rubella and Mumps: A Cross-Sectional Study of a First Measles and Rubella Vaccination and a Second Measles, Mumps, and Rubella Vaccination
por: Wang, Zhifang, et al.
Publicado: (2014)

Measles and rubella microarray array patches to increase vaccination coverage and achieve measles and rubella elimination in Africa
por: Richardson, Lauren Christine, et al.
Publicado: (2020)

Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges
por: Hasso-Agopsowicz, Mateusz, et al.
Publicado: (2022)

Purulent Bronchitis Complicating Measles and Rubella
Publicado: (1919)

Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey
por: Hayford, Kyla, et al.
Publicado: (2019)

Genetic Characterization of Measles and Rubella Viruses Detected Through Global Measles and Rubella Elimination Surveillance, 2016–2018
por: Brown, Kevin E., et al.
Publicado: (2019)

Measles and rubella serosusceptibity among population vaccinated with different schedules: the potential impact on measles-rubella elimination in Iran
por: Saffar, Hana, et al.
Publicado: (2021)

Measles & rubella outbreaks in Maharashtra State, India
por: Vaidya, Sunil R., et al.
Publicado: (2016)

Rubella and Its Relations to Scarlet Fever and Measles
Publicado: (1908)

2017 Measles-Rubella Vaccination Campaign in India
por: Shrivastava, Saurabh RamBihariLal, et al.
Publicado: (2018)

Differential Diagnosis of Scarlet Fever, Measles and Rubella
Publicado: (1919)

COVID-19 testing, timeliness and positivity from ICMR’s laboratory surveillance network in India: Profile of 176 million individuals tested and 188 million tests, March 2020 to January 2021
por: Ponnaiah, Manickam, et al.
Publicado: (2021)

Modified measles versus rubella versus atypical measles: One and same thing
por: Gupta, Surender Nikhil, et al.
Publicado: (2015)

Age- & sex-specific infection fatality ratios for COVID-19 estimated from two serially conducted community-based serosurveys, Chennai, India, 2020
por: Vivian Thangaraj, Jeromie Wesley, et al.
Publicado: (2021)

Integrating Blood Collection within Household Surveys: Lessons Learned from Nesting a Measles and Rubella Serological Survey within a Post-Campaign Coverage Evaluation Survey in Southern Province, Zambia
por: Mutembo, Simon, et al.
Publicado: (2018)

The impact of Measles-Rubella vaccination on the morbidity and mortality from Congenital Rubella Syndrome in 92 countries
por: Vynnycky, Emilia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ku5tt3pr6uia4ki012762trbgr